REHOVOT, Israel, JERSEY CITY, New Jersey and PHILADELPHIA, December 11 — Rosetta Genomics, Ltd. (NASDQ: ROSG), a leading developer of microRNA-based molecular diagnostics, announced today the commercial availability of its first diagnostic test, miRview(TM) squamous. The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia. To order the test, physicians may contact […]
Health & Medicine Press release from: Protagen AG PR Agency: Dr. Holger Bengs Biotech Consulting (openPR) – Dortmund, Germany and New Jersey, USA, December 3, 2008. Protagen AG announces the closing of a cooperation contract with Bayer HealthCare AG, Leverkusen, Germany, about the evaluation of the UNIarray® technology for discovery of novel biomarkers in atrial […]
Omaha, NE, December 9, 2008 – Transgenomic, Inc. (OTC-Bulletin Board: TBIO.OB) today announced that its laboratory has been awarded an accreditation by the Commission on Laboratory Accreditation of the College of American Pathologists (CAP), based on the results of a recent on-site inspection. Transgenomic is now one of the more than 6,000 CAP-accredited laboratories nationwide. […]
REYKJAVIK, Iceland, Dec. 8 — deCODE genetics (Nasdaq: DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the human genome (SNP) that is associated with increased fasting glucose levels and risk of type 2 diabetes (T2D). deCODE will […]
Asuragen, Inc. announced today that the Signature® LTx v2.0 Leukemia Translocation Panel was released as a “Conformité Européenne” or “European Conformity” CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The CE-marked Signature® LTx v2.0 is a qualitative in vitro diagnostic device for use in a clinical laboratory to identify specific […]
JENA, Germany–SIRS-Lab today announced that the EU regulatory authorities have granted the CE mark for VYOO, a molecular diagnostic test for pathogen detection in sepsis. With VYOO, clinicians can rapidly and reliably identify causative pathogens as well as important antibiotic resistance markers. Therefore VYOO allows for a customized anti-infective therapy in each patient within the […]
Clarient, Inc. (Nasdaq:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, today announced the commercial launch of its new BRAF gene mutation test which has been validated as a laboratory-developed test to be used as a predictive molecular biomarker for patients with colorectal cancer (CRC). The importance […]
BioTrove Inc. and Gene Express, Inc. today announced an exclusive co-marketing agreement to test market a standardized genetic profiling test for indicators of lung cancer risk. Supported by a two-year National Institutes of Health (NIH) grant, the new profiling test combines BioTrove’s OpenArray® nanofluidic polymerase chain reaction (PCR) technology platform, Gene Express standards for accurate […]
Will offer proteomic tests to identify Alzheimer’s and Parkinson’s disease OMAHA, Neb. and HOUSTON, Dec. 2 — Transgenomic, Inc. (OTC Bulletin Board: TBIO – News) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM – News) today announced that Transgenomic has signed a letter of intent to acquire exclusive rights for Power3 Medical’s Neurodegenerative Biomarkers, […]
WALTHAM, Mass., Dec 02, 2008 — Decision Biomarkers Inc, a leading developer of protein biomarker analysis systems for pharmaceutical research and development, today announced the formation of a Scientific Advisory Board consisting of internationally renowned scientists and physicians at the forefront of biomarker and clinical research. The Scientific Advisory Board includes: — Daniel W. Chan, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
